Inhibition of the renin–angiotensin–aldosterone system

Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease

(2013) Regina Kunz et al.   ANNALS OF INTERNAL MEDICINE

Redefining Blood Pressure Targets in High-Risk Patients?: Lessons From Coronary Endpoints in Recent Randomized Clinical Trials

(2011) M. Volpe et al.   AMERICAN JOURNAL OF HYPERTENSION

Renal function and target organ damage in hypertension

(2011) L. M. Ruilope et al.   EUROPEAN HEART JOURNAL

Changes in Albuminuria Predict Mortality and Morbidity in Patients with Vascular Disease

(2011) R. E. Schmieder et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

(2011) Hermann Haller et al.   NEW ENGLAND JOURNAL OF MEDICINE

Aldosterone and cardiovascular disease

(2011) Robert M Carey   Current Opinion in Endocrinology Diabetes and Obesity

Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical Utility

(2011) Lanqi Jia et al.   ACS Medicinal Chemistry Letters

Blood pressure targets of antihypertensive treatment: up and down the J-shaped curve

(2010) A. Zanchetti   EUROPEAN HEART JOURNAL

DUAL INHIBITION OF CLASSICAL PKC-ALPHA AND PKC-BETA-ISOFORMS IN A PHARMACOLOGICAL AND DOUBLE KNOCK-OUT MOUSE APPROACH LEADS TO PROTECTION AGAINST DIABETIC NEPHROPATHY: 5A.04

(2010) J Menne et al.   JOURNAL OF HYPERTENSION

Left Ventricular Mass and Volume With Telmisartan, Ramipril, or Combination in Patients With Previous Atherosclerotic Events or With Diabetes Mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])

(2009) Brett R. Cowan et al.   AMERICAN JOURNAL OF CARDIOLOGY

Design of Combination Angiotensin Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor for Treatment of Diabetic Nephropathy (VA NEPHRON-D)

(2009) L. F. Fried et al.   Clinical Journal of the American Society of Nephrology

Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease: A Systematic Review and Meta-analysis

(2009) S. D. Navaneethan et al.   Clinical Journal of the American Society of Nephrology

Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced?

(2009) Alberto Zanchetti   JOURNAL OF HYPERTENSION

Aldosterone-receptor antagonism in hypertension

(2009) Pieter M Jansen et al.   JOURNAL OF HYPERTENSION

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

(2009) Giuseppe Mancia et al.   JOURNAL OF HYPERTENSION

The Kidney, Hypertension, and Remaining Challenges

(2009) Nitin Khosla et al.   MEDICAL CLINICS OF NORTH AMERICA

Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design

(2009) H.-H. Parving et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Change in Proteinuria After Adding Aldosterone Blockers to ACE Inhibitors or Angiotensin Receptor Blockers in CKD: A Systematic Review

(2008) Andrew S. Bomback et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Aliskiren-Binding Increases the Half Life of Renin and Prorenin in Rat Aortic Vascular Smooth Muscle Cells

(2008) Wendy W. Batenburg et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Renal and Hormonal Responses to Direct Renin Inhibition With Aliskiren in Healthy Humans

(2008) Naomi D.L. Fisher et al.   CIRCULATION

Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial

(2008) K. J. Schjoedt et al.   DIABETOLOGIA

Renin-angiotensin system revisited

(2008) F. Fyhrquist et al.   JOURNAL OF INTERNAL MEDICINE

Update on tissue renin–angiotensin systems

(2008) Michael Bader et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

(2008) Johannes FE Mann et al.   LANCET

Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy

(2008) Hans-Henrik Parving et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE